Nox as a target for diabetic complications.

Area of Science:

• Biochemistry
• Cell Biology
• Pharmacology

Background:

• Oxidative stress is implicated in diabetic complications affecting organs like the kidney, heart, and vasculature.
• NADPH oxidases (Nox) are significant sources of reactive oxygen species (ROS) and central to redox signaling in diabetic conditions.

Purpose of the Study:

• To review the role of Nox enzymes in hyperglycemia-induced cell injury and diabetic complications.
• To explore the involvement of factors like the renin-angiotensin system, TGF-β, and AGEs in Nox-mediated damage.
• To assess the therapeutic potential of Nox inhibitors for diabetic complications.

Main Methods:

• Literature review of current knowledge on Nox family enzymes in diabetes.
• Analysis of studies investigating hyperglycemia, renin-angiotensin system, TGF-β, and AGEs in relation to Nox activity.
• Evaluation of data on small-molecule Nox inhibitors and their efficacy in preclinical models.

Main Results:

• Nox enzymes are critical mediators of cell injury in diabetes.
• Hyperglycemia, renin-angiotensin system, TGF-β, and AGEs contribute to Nox-driven damage.
• Small-molecule Nox inhibitors show promise in experimental models for preventing diabetic complications.

Conclusions:

• Nox homologues play a crucial role in the pathogenesis of diabetic complications.
• NADPH oxidases represent a significant therapeutic target for managing diabetes-related organ damage.
• Development of selective Nox inhibitors is a viable strategy to mitigate diabetic complications.